Skip to main content

Trexquant Investment LP

Source: SEC Form 13F · as of Mar 2026

Trexquant Investment LP holds 79 biotech & pharma companies tracked by BioSniper, totaling $363.8M in value as of Mar 2026 (SEC Form 13F).

Companies held

79

Total value held

$363.8M

BioSniper AIPage context preserved

Prepared research question

What matters most for Moderna, Inc. (MRNA)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
MRNAModerna, Inc.483,971$24.6M
ALNYALNYLAM PHARMACEUTICALS, INC.61,760$20.4M
ARWRARROWHEAD PHARMACEUTICALS, INC.277,114$17.4M
EXELEXELIXIS, INC.390,818$16.8M
IONSIONIS PHARMACEUTICALS INC213,645$16.0M
CNTACentessa Pharmaceuticals plc390,951$15.5M
LQDALiquidia Corp409,259$15.4M
TGTXTG THERAPEUTICS, INC.311,219$10.3M
ADMAADMA BIOLOGICS, INC.1,144,841$10.3M
MLTXMoonLake Immunotherapeutics495,336$9.2M
REGNREGENERON PHARMACEUTICALS, INC.11,072$8.6M
APLSApellis Pharmaceuticals, Inc.205,219$8.3M
ADPTAdaptive Biotechnologies Corp571,584$7.9M
SLNOSOLENO THERAPEUTICS INC221,928$7.4M
BHVNBiohaven Ltd.877,774$7.4M
VCELVericel Corp227,263$7.3M
CAPRCAPRICOR THERAPEUTICS, INC.222,413$6.8M
RVMDREVOLUTION MEDICINES, INC.68,609$6.7M
KNSAKiniksa Pharmaceuticals International, plc135,280$6.5M
INCYIncyte Corp.57,696$5.4M
ABVXAbivax SA48,749$5.4M
ACADACADIA PHARMACEUTICALS INC235,946$5.3M
GPCRStructure Therapeutics Inc.107,884$5.2M
ARGXARGENX SE7,009$5.1M
DNTHDianthus Therapeutics, Inc. /DE/59,077$5.0M
OLMAOlema Pharmaceuticals, Inc.325,173$4.8M
XERSXeris Biopharma Holdings, Inc.833,217$4.8M
ARDXARDELYX, INC.804,734$4.8M
ANABANAPTYSBIO, INC85,167$4.7M
KODKodiak Sciences Inc.123,402$4.7M
PVLAPALVELLA THERAPEUTICS, INC.36,639$4.6M
KURAKura Oncology, Inc.528,704$4.3M
CTMXCytomX Therapeutics, Inc.898,767$4.2M
ANIPANI PHARMACEUTICALS INC54,607$4.2M
COGTCogent Biosciences, Inc.107,443$4.1M
NKTRNEKTAR THERAPEUTICS55,476$4.0M
SRRKScholar Rock Holding Corp76,748$3.8M
NRIXNurix Therapeutics, Inc.209,694$3.3M
CYTKCYTOKINETICS INC48,190$3.2M
ELVNEnliven Therapeutics, Inc.78,248$3.1M
PCVXVaxcyte, Inc.49,212$2.9M
KALVKalVista Pharmaceuticals, Inc.139,458$2.8M
AGIOAGIOS PHARMACEUTICALS, INC.75,298$2.5M
OGNOrganon & Co.402,790$2.4M
CGEMCullinan Therapeutics, Inc.168,473$2.4M
ANNXAnnexon, Inc.403,657$2.2M
CMPXCompass Therapeutics, Inc.421,831$2.2M
TEVATeva Pharmaceutical Industries Limited68,054$2.0M
LENZLENZ Therapeutics, Inc.214,408$2.0M
FBRXForte Biosciences, Inc.73,651$1.9M
PHVSPharvaris N.V.66,121$1.9M
CMPSCOMPASS Pathways plc309,283$1.7M
UPBUpstream Bio, Inc.176,657$1.6M
ARVNARVINAS, INC.146,387$1.6M
DSGNDesign Therapeutics, Inc.117,111$1.2M
ONCBeOne Medicines Ltd.4,037$1.2M
BIOABioAge Labs, Inc.60,572$1.1M
TRDAEntrada Therapeutics, Inc.82,733$1.0M
NUVLNuvalent, Inc.10,049$1.0M
AXSMAxsome Therapeutics, Inc.5,935$1.0M
GHRSGH Research PLC69,808$982K
SLDBSolid Biosciences Inc.123,906$892K
STROSUTRO BIOPHARMA, INC.34,343$855K
TENXTENAX THERAPEUTICS, INC.50,712$811K
VKTXViking Therapeutics, Inc.22,728$740K
IMVTImmunovant, Inc.25,692$638K
KRROKorro Bio, Inc.56,208$636K
ASMBASSEMBLY BIOSCIENCES, INC.22,741$631K
IMCRImmunocore Holdings plc20,685$624K
SVRASavara Inc114,198$624K
SIGASIGA TECHNOLOGIES INC93,440$500K
ARQTArcutis Biotherapeutics, Inc.17,042$402K
JBIOJade Biosciences, Inc.28,107$395K
FENCFENNEC PHARMACEUTICALS INC.51,869$319K
ORICOric Pharmaceuticals, Inc.23,972$304K
ACETAdicet Bio, Inc.43,666$297K
PRTAPROTHENA CORP PUBLIC LTD CO24,543$239K
DMACDiaMedica Therapeutics Inc.22,261$151K
NUVBNuvation Bio Inc.21,559$92K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.